PATHOLOGY INTERNATIONAL, published by WILEY, stands as a distinguished journal in the field of pathology and forensic medicine, serving as an essential resource for researchers, clinicians, and students alike. With its ISSN 1320-5463 and E-ISSN 1440-1827, PATHOLOGY INTERNATIONAL has established itself since its inception in 1951, navigating through an evolving landscape in medical science with insights and breakthroughs up to 2024. It holds a commendable Q2 ranking in both the Medicine (miscellaneous) and Pathology and Forensic Medicine categories, indicating its robust influence and quality within these fields, as evidenced by its placement in the 70th percentile of Scopus rankings. While currently not an open-access journal, it provides access options that ensure valuable research remains available to the academic community. PATHOLOGY INTERNATIONAL commits to advancing the discipline through pioneering research articles, comprehensive reviews, and expert opinions that push the boundaries of understanding in pathology, thereby supporting the enhancement of diagnostic and therapeutic practices.

Annals of Diagnostic Pathology, published by Elsevier Science Inc, is a pivotal journal in the field of diagnostic pathology that has significantly contributed to the advancement of medical science since its inception in 1997. With an ISSN of 1092-9134 and E-ISSN of 1532-8198, this esteemed journal is positioned within the Q2 category in both Medicine (miscellaneous) and Pathology and Forensic Medicine, reflecting its high-quality research contributions, showcased by its ranking at #73 out of 208 in Scopus for the latter category. The journal's scope encompasses various aspects of diagnostic pathology, from innovative techniques to critical reviews of pathologic findings, making it an essential resource for researchers, medical professionals, and students dedicated to enhancing diagnostic accuracy and patient care. Although it does not currently offer open access options, its wide readership and impactful publications continue to influence clinical practices and research agendas. With a convergence period extending to 2024, Annals of Diagnostic Pathology remains a leading platform for disseminating valuable knowledge in this dynamic field.

ENDOCRINE PATHOLOGY is a premier journal published by HUMANA PRESS INC, dedicated to advancing the understanding of endocrine disorders through innovative research and clinical practices. With an impressive impact factor and consistently ranked in the Q1 quartile across multiple categories such as Endocrinology, Diabetes and Metabolism, as well as Pathology and Forensic Medicine, this journal serves as a pivotal resource for researchers and professionals in the field. The journal covers a broad spectrum of topics related to endocrine pathology, providing insights into mechanisms, diagnostics, and therapeutics that inform both clinical and laboratory practices. Although it does not offer open access, its rigorous peer-review process ensures the dissemination of high-quality, impactful research that shapes clinical strategies and enhances patient care. With distribution spanning from its inception in 1990 to 2024, ENDOCRINE PATHOLOGY stands at the forefront of endocrine research, making it an essential read for anyone involved in the study and treatment of endocrine disorders.

HISTOPATHOLOGY is a premier scholarly journal published by WILEY, targeting the fields of histology, pathology, and forensic medicine. With an ISSN of 0309-0167 and an E-ISSN of 1365-2559, this esteemed journal has maintained a strong academic presence since its inception in 1977. Boasting an impressive Q1 ranking in crucial categories such as Histology and Pathology, it ranks 13th out of 208 in Pathology and Forensic Medicine, and 5th out of 62 in Histology, reflecting its high impact and relevance within the scientific community. HISTOPATHOLOGY serves as a critical platform for disseminating significant research findings, reviews, and advancements in the diagnostic and therapeutic aspects of pathology. Although it does not operate under an open access model, its rigorous peer-review process ensures that published articles uphold the highest standards of scientific integrity. Scholars and practitioners alike benefit from the insights shared in this journal, as it aims to bridge the gap between laboratory science and clinical practice, fostering innovation and enhancing our understanding of disease mechanisms.

Malaysian Journal of Pathology, published by the MALAYSIAN JOURNAL PATHOLOGY, stands as a pivotal resource in the fields of pathology and medicine, contributing rich insights since its inception in 1979. This peer-reviewed journal, based in Malaysia, is dedicated to disseminating original research, review articles, and case studies that advance the understanding of disease mechanisms and diagnostics. With a current impact factor reflecting its ranked positioning—Q4 in Cell Biology, Q4 in Histology, and Q3 in both Miscellaneous Medicine and Pathology & Forensic Medicine—this journal serves as an essential platform for researchers, clinicians, and students alike. Although it operates without open access, its scholarly rigor and contributions are well recognized, holding ranks such as #84 in Pathology and Forensic Medicine according to Scopus. The Malaysian Journal of Pathology is committed to fostering innovation and excellence in medical research, making it an invaluable tool for professionals seeking to stay abreast of significant advancements in the pathology domain.

Welcome to the Journal of Pathology, a premier academic publication specializing in the field of pathology and forensic medicine. Established in 1969 and published by Wiley, this journal has garnered significant recognition within the research community, reflected in its impressive ranking of #6 out of 208 in Scopus, placing it in the 97th percentile. The Journal of Pathology serves as a critical platform for disseminating cutting-edge research findings, innovative methodologies, and topical reviews that advance our understanding of diseases and their underlying mechanisms. With no open access charge, this esteemed journal is committed to maintaining the highest standards of scientific rigor and integrity. As a Q1 journal in its category for 2023, it continues to shape the field of pathology and contribute invaluable insights to researchers, medical professionals, and students alike. We invite you to explore the wealth of knowledge encapsulated in each issue and engage with the vibrant discussions that strive to propel the science of pathology forward.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

ACTA HISTOCHEMICA, a prestigious journal published by Elsevier GmbH, is dedicated to advancing the field of histochemistry and its applications within cell biology and medicine. With an ISSN of 0065-1281 and an E-ISSN of 1618-0372, the journal provides a critical platform for the dissemination of high-quality research findings and reviews, integral for both emerging and established scholars. Since its inception in 1954 and continuing through to 2024, ACTA HISTOCHEMICA has maintained a strong commitment to publishing significant advancements in histology and cell biology, as evidenced by its categorization in Q3 for Cell Biology and Histology, as well as Q2 in miscellaneous medicine for the year 2023. The journal ranks favorably in Scopus, holding the 27th rank in Histology and a 200th rank in Cell Biology, highlighting its importance to the academic community. With its headquarters in Munich, Germany, ACTA HISTOCHEMICA continues to attract contributions from global researchers, fostering an international dialogue essential for the growth of knowledge in histochemistry and related disciplines.

MODERN PATHOLOGY is a premier journal in the field of pathology and forensic medicine, published by Elsevier Science Inc. With an impressive impact factor that places it in the top 1st quartile (Q1) for 2023, and a remarkable rank of 5 out of 208 in its category according to Scopus, it serves as a vital resource for researchers, professionals, and students alike. Established in 1988, the journal focuses on the latest advancements in diagnostic pathology, molecular pathology, and related fields, providing a platform for innovative research that drives the discipline forward. Although it does not operate under an open access model, readers can expect rigorously peer-reviewed publications that contribute to the growing body of knowledge in pathology. With a continuous commitment to excellence and relevance, MODERN PATHOLOGY remains a fundamental avenue for disseminating high-quality scientific research globally, facilitating the growth and development of its field.

JOURNAL OF CLINICAL PATHOLOGY, published by BMJ PUBLISHING GROUP, stands at the forefront of advancements in the field of clinical pathology, offering a platform for groundbreaking research and insights from 1948 to the present. With an impressive impact factor and categorized as Q1 in both Medicine (miscellaneous) and Pathology and Forensic Medicine for 2023, the journal holds a distinguished position in the academic community, ranking 22nd out of 208 journals in its category on Scopus and representing the 89th percentile. While the journal does not currently offer open access, it remains a vital resource for researchers, healthcare professionals, and students seeking to stay current with innovative methodologies, clinical techniques, and diagnostic advancements. Located in London, United Kingdom, the journal aims to bridge the gap between laboratory findings and clinical practice, emphasizing the importance of evidence-based pathology in improving patient care and treatment outcomes. Engage with the JOURNAL OF CLINICAL PATHOLOGY to enhance your understanding and contribute to the evolving landscape of clinical pathology research.